Holen Sie sich die Stockscreener-App
1.37
6.20%
0.08
Handel nachbörslich:
1.34
-0.03
-2.19%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.31
24-Stunden-Volumen:
247.70K
Relative Volume:
1.32
Marktkapitalisierung:
$5.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1604
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
+0.00%
1M Leistung:
+13.22%
6M Leistung:
-75.89%
1J Leistung:
-85.51%
1-Tages-Spanne:
$1.29
$1.39
1-Wochen-Bereich:
$1.27
$1.45
52-Wochen-Spanne:
$1.01
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.37 | 5.32M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
Has Oragenics Inc. formed a bullish divergenceJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
How to use Fibonacci retracement on Oragenics Inc.July 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Will Oragenics Inc. bounce back from current supportMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Applying Wyckoff theory to Oragenics Inc. stockTake Profit & Precise Swing Trade Entry Alerts - newser.com
How institutional ownership impacts Oragenics Inc. stockJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Combining machine learning predictions for Oragenics Inc.Dividend Hike & Proven Capital Preservation Tips - newser.com
What the charts say about Oragenics Inc. todayWeekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Analyzing Oragenics Inc. with multi timeframe chartsJuly 2025 Institutional & Technical Buy Zone Confirmation - newser.com
Is Oragenics Inc. meeting your algorithmic filter criteria2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Why Oragenics Inc. stock could benefit from AI revolutionJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
What’s the recovery path for long term holders of Oragenics Inc.Quarterly Profit Report & Growth Focused Entry Reports - newser.com
Why Oragenics Inc. stock fits value portfoliosJuly 2025 Summary & Daily Stock Trend Reports - newser.com
What machine learning models say about Oragenics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
Using economic indicators to assess Oragenics Inc. potentialTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Oragenics Inc. stock attractive for growth ETFs2025 Biggest Moves & Fast Moving Market Watchlists - newser.com
Oragenics partners Receptor.AI for brain health candidate portfolio - Yahoo Finance
Oragenics Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Targeted Therapeutics - citybuzz
Press Telegram - FinancialContent
Oragenics (OGEN) Collaborates with Receptor.AI for Drug Developm - GuruFocus
Oragenics (OGEN) Partners with Receptor.AI to Enhance Drug Devel - GuruFocus
Oragenics partners with Receptor.AI to expand brain therapeutics pipeline By Investing.com - Investing.com Australia
Oragenics announces strategic partnership with Receptor.AI to accelerate pipeline development - MarketScreener
Oragenics partners with Receptor.AI to expand brain therapeutics pipeline - Investing.com
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development - MarketScreener
Can Oragenics Inc. stock beat analyst consensusLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Will Oragenics Inc. stock beat Nasdaq index returnsPortfolio Gains Report & Real-Time Sentiment Analysis - newser.com
Trend analysis for Oragenics Inc. this weekJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com
Will Oragenics Inc. stock benefit from mergersExit Point & Weekly Momentum Picks - newser.com
A activity2025 Winners & Losers & Technical Entry and Exit Tips - newser.com
Oragenics Inc Stock Analysis and ForecastInstitutional Buying Trends & Superior Capital Investment - earlytimes.in
Can Oragenics Inc. hit a new high this monthJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Measuring Oragenics Inc.’s beta against major indicesTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
Is Oragenics Inc. stock testing key support2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):